-
A controlled surgical trial of glutamic acid decarboxylase gene therapy, targeting the subthalamic nucleus in advanced Parkinsons's disease, demonstrated statistically significant improvement in motor symptoms off medication in those receiving gene therapy compared with controls.
-
Noroviruses are the major single cause of gastroenteritis outbreaks throughout the world and the leading cause of foodborne disease in the United States.
-
Therapeutic hypothermia does not result in improved outcomes in patients with traumatic brain injury.
-
This study of outcomes among more than 50,000 elderly Medicare beneficiaries found that activities of daily living and mobility had deteriorated substantially more among those who had been hospitalized the previous year, and that only 27% of those who had received mechanical ventilation were alive 1 year after hospitalization.
-
-
Bacterial transmission to the IV stopcock set was documented in 19/164 cases (11.5%); 47% of these cases were of provider origin and linked to hands of anesthesia providers.
-
Patients presenting with acute coronary syndromes (ACS) should be administered dual anti-platelet therapy with aspirin and a thienopyridine, such as clopidogrel. However, some patients are subsequently found to have left main (LM) or multivessel disease (MVD) and require coronary artery bypass graft (CABG) surgery.
-
-
-
In this issue: Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.